The cytomegalovirus (CMV), a common virus included in the herpesviruses group that infects people of all ages, is linked to inflammatory bowel disease, according to the researchers at the Center for the Biology of Chronic Disease (CBCD), a not-for-profit organization specialized in researching the biology of foreign DNA.

Information available on the Centers for Disease Control and Prevention‘s website describes CMV as a usually harmless virus that is generally passed from infected people to others through direct contact with bodily fluids, such as urine, saliva, or breast milk. Among every 100 adults in the United States, about 50 to 80 are infected with CMV by the time they are 40 years old. Although usually harmless, the virus can cause fever, sore throat, fatigue, and swollen glands.

Researchers at the CBCB noted that patients with Crohn’s disease had more often detectable CMV genome in their intestinal tissue samples as compared with controls, as well as patients with ulcerative colitis had more often detectable CMV genome in their blood and in their intestinal tissue samples. Basically, IBD patients have CMV DNA in their guts.

The research center already came up with solutions. In two clinical studies, one of which published in the medical journal Pharmacology & Pharmacy, the CBCB evaluated the natural products Novirin and Gene-Eden-VIR as safe and effective antiviral treatments against these viruses.

Gene-Eden-VIR formula includes five natural ingredients: Camellia Sinensis Extract, Quercetin, Licorice Extract, Cinnamomum Extract, and Selenium, the same five ingredients that compose Novirin.

Acknowledging that the key to one’s health is to reduce the number of latent viruses in their body to harmless levels, both these natural antivirals dietary supplements were designed to target latent viruses. The CBCB believes precisely that using Novirin or Gene-Eden-VIR is will help the immune system to target the latent CMV in the body, which may be necessary since CMV sometimes induces inflammation and at the same time avoids recognition by the immune system.

According to the study, participants who took Gene-Eden-VIR reported no side effects, with 73% of the individuals treated with this antiviral reporting a decrease in their symptoms. Specifically, they reported a decrease in the severity, duration, and frequency of their symptoms.

Following treatment, the participants also reported an increase in their physical abilities, energy levels, mental abilities, and general health. The results showed as well that Gene-Eden-VIR has a duration effect, that is, those treated for a longer time reported a larger decrease in their symptoms.